Global Gout Therapeutics Market 2016-2020
- SKU ID : TNV-IRTNTR10483 10346361
- |
- Publishing Date: 25-Oct-2016
- |
- Region: Global
- |
- No. of pages: 59
About Gout Therapeutics
Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.
Technavio’s analysts forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• Horizon Pharma
• Takeda Pharmaceuticals
Other prominent vendors
• Ablynx
• Alder Biopharmaceuticals
• Antares Pharma
• Astellas Pharma
• Boehringer Ingelheim
• Can-Fite BioPharma
• Celgene
• Celltrion
• ChemoCentryx
• CymaBay Therapeutics
• Eisai
• Eli Lilly
• Gilead Sciences
• GlaxoSmithKline
• Incyte
• Ironwood Pharmaceuticals
• JW Pharmaceutical
• KaloBios Pharmaceuticals
• Lexicon Pharmaceuticals
• LG Life Sciences
• Merck
• Morphotek
• Novartis
• Novo Nordisk
• Regeneron Pharmaceuticals
• Sandoz
• Sanofi
• Santarus
• Selecta Biosciences
• Teijin Pharma
• UCB
• Vertex Pharmaceuticals.
Market driver
• Introduction of novel urate-lowering agents
• For a full, detailed list, view our report
Market challenge
• Low physician and patient awareness
• For a full, detailed list, view our report
Market trend
• Focus on regenerative medicines
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.
Technavio’s analysts forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• Horizon Pharma
• Takeda Pharmaceuticals
Other prominent vendors
• Ablynx
• Alder Biopharmaceuticals
• Antares Pharma
• Astellas Pharma
• Boehringer Ingelheim
• Can-Fite BioPharma
• Celgene
• Celltrion
• ChemoCentryx
• CymaBay Therapeutics
• Eisai
• Eli Lilly
• Gilead Sciences
• GlaxoSmithKline
• Incyte
• Ironwood Pharmaceuticals
• JW Pharmaceutical
• KaloBios Pharmaceuticals
• Lexicon Pharmaceuticals
• LG Life Sciences
• Merck
• Morphotek
• Novartis
• Novo Nordisk
• Regeneron Pharmaceuticals
• Sandoz
• Sanofi
• Santarus
• Selecta Biosciences
• Teijin Pharma
• UCB
• Vertex Pharmaceuticals.
Market driver
• Introduction of novel urate-lowering agents
• For a full, detailed list, view our report
Market challenge
• Low physician and patient awareness
• For a full, detailed list, view our report
Market trend
• Focus on regenerative medicines
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
